Clinical Trial Update: Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the combination of pyrimethamine, sulfadiazine, and leucovorin for congenital toxoplasmosis, and the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Toxoplasmosis

Drugs mentioned

• Daraprim (pyrimethamine)
• Leucovorin (folinic acid)
• Sulfadiazine (Sulfadiazine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Toxoplasmosis | Phase 4 | Status: RECRUITING